Linzess is a Oral Capsule, Gelatin Coated in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Linaclotide.
| Product ID | 0456-1201_114152bc-d286-4228-9b01-9814473d3875 |
| NDC | 0456-1201 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Linzess |
| Generic Name | Linaclotide |
| Dosage Form | Capsule, Gelatin Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2012-09-08 |
| Marketing Category | NDA / NDA |
| Application Number | NDA202811 |
| Labeler Name | Allergan, Inc. |
| Substance Name | LINACLOTIDE |
| Active Ingredient Strength | 145 ug/1 |
| Pharm Classes | Guanylate Cyclase-C Agonist [EPC],Guanylate Cyclase Activators [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2012-09-08 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA202811 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-09-08 |
| Marketing Category | NDA |
| Application Number | NDA202811 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2012-09-08 |
| Ingredient | Strength |
|---|---|
| LINACLOTIDE | 145 ug/1 |
| SPL SET ID: | 09beda19-56d6-4a56-afdc-9a77b70b2ef3 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0456-1201 | Linzess | linaclotide |
| 0456-1202 | Linzess | linaclotide |
| 0456-1203 | Linzess | linaclotide |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() LINZESS 85773175 4614364 Live/Registered |
Ironwood Pharmaceuticals, Inc. 2012-11-06 |
![]() LINZESS 77872111 4328588 Live/Registered |
Ironwood Pharmaceuticals, Inc. 2009-11-13 |